FR2657258B1 - - Google Patents

Info

Publication number
FR2657258B1
FR2657258B1 FR9000624A FR9000624A FR2657258B1 FR 2657258 B1 FR2657258 B1 FR 2657258B1 FR 9000624 A FR9000624 A FR 9000624A FR 9000624 A FR9000624 A FR 9000624A FR 2657258 B1 FR2657258 B1 FR 2657258B1
Authority
FR
France
Prior art keywords
agents
unit form
new solid
pearls
administration
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR9000624A
Other languages
English (en)
French (fr)
Other versions
FR2657258A1 (fr
Inventor
Anne Coutel
Guy Lebreton
Michel Veillard
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Farmalyoc
Original Assignee
Farmalyoc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to FR9000624A priority Critical patent/FR2657258A1/fr
Application filed by Farmalyoc filed Critical Farmalyoc
Priority to AT9191400105T priority patent/ATE104847T1/de
Priority to DK91400105.2T priority patent/DK0438358T3/da
Priority to EP91400105A priority patent/EP0438358B1/de
Priority to DE69101792T priority patent/DE69101792T2/de
Priority to ES91400105T priority patent/ES2063455T3/es
Priority to JP3019511A priority patent/JP2912459B2/ja
Publication of FR2657258A1 publication Critical patent/FR2657258A1/fr
Priority to US08/057,407 priority patent/US5417985A/en
Application granted granted Critical
Publication of FR2657258B1 publication Critical patent/FR2657258B1/fr
Granted legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682—Processes
    • A61K9/1694—Processes resulting in granules or microspheres of the matrix type containing more than 5% of excipient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Physiology (AREA)
  • Nutrition Science (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Glanulating (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
FR9000624A 1989-07-20 1990-01-19 Nouvelle forme unitaire, solide et poreuse comprenant des particules sous forme de perles ainsi que sa preparation. Granted FR2657258A1 (fr)

Priority Applications (8)

Application Number Priority Date Filing Date Title
FR9000624A FR2657258A1 (fr) 1990-01-19 1990-01-19 Nouvelle forme unitaire, solide et poreuse comprenant des particules sous forme de perles ainsi que sa preparation.
DK91400105.2T DK0438358T3 (da) 1990-01-19 1991-01-18 Fast og porøs enhedsform indeholdende partikler i form af perler samt dens fremstilling
EP91400105A EP0438358B1 (de) 1990-01-19 1991-01-18 Feste und poröse Einzeldosisform, enthaltend Perlpartikel und Verfahren zu ihrer Herstellung
DE69101792T DE69101792T2 (de) 1990-01-19 1991-01-18 Feste und poröse Einzeldosisform, enthaltend Perlpartikel und Verfahren zu ihrer Herstellung.
AT9191400105T ATE104847T1 (de) 1990-01-19 1991-01-18 Feste und poroese einzeldosisform, enthaltend perlpartikel und verfahren zu ihrer herstellung.
ES91400105T ES2063455T3 (es) 1990-01-19 1991-01-18 Nueva forma unitaria, solida y porosa que comprende particulas en forma de perlas asi como su preparacion.
JP3019511A JP2912459B2 (ja) 1990-01-19 1991-01-19 ビーズ及びその調製物を含む固体多孔質単位剤形
US08/057,407 US5417985A (en) 1989-07-20 1993-05-06 Solid and porous single dosage form comprising particles in the form of beads and its preparation

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9000624A FR2657258A1 (fr) 1990-01-19 1990-01-19 Nouvelle forme unitaire, solide et poreuse comprenant des particules sous forme de perles ainsi que sa preparation.

Publications (2)

Publication Number Publication Date
FR2657258A1 FR2657258A1 (fr) 1991-07-26
FR2657258B1 true FR2657258B1 (de) 1994-08-19

Family

ID=9392949

Family Applications (1)

Application Number Title Priority Date Filing Date
FR9000624A Granted FR2657258A1 (fr) 1989-07-20 1990-01-19 Nouvelle forme unitaire, solide et poreuse comprenant des particules sous forme de perles ainsi que sa preparation.

Country Status (7)

Country Link
EP (1) EP0438358B1 (de)
JP (1) JP2912459B2 (de)
AT (1) ATE104847T1 (de)
DE (1) DE69101792T2 (de)
DK (1) DK0438358T3 (de)
ES (1) ES2063455T3 (de)
FR (1) FR2657258A1 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5656283A (en) * 1995-06-08 1997-08-12 Ortho Pharmaceutical Corporation In-situ lyophilization of vaginal suppository in unit dose applicator and resultant product
DE19705538C1 (de) * 1997-02-14 1998-08-27 Goedecke Ag Verfahren zur Trennung von Wirkstoffen in festen pharmazeutischen Zubereitungen

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3433872A (en) * 1966-11-25 1969-03-18 Hoffmann La Roche Palatable,free-flowing,non-agglomerating caffeine powder
FR2036890B1 (de) 1969-04-15 1973-01-12 Orsymonde
IE45770B1 (en) 1976-10-06 1982-11-17 Wyeth John & Brother Ltd Pharmaceutical dosage forms
CA1154213A (en) * 1981-07-07 1983-09-27 John T. Higgins Sulfur prilling
US4793783A (en) * 1987-01-20 1988-12-27 The Dow Chemical Company Apparatus for producing prills
FR2613223B1 (fr) * 1987-04-03 1991-09-13 Biogalenique Laboratoires Forme galenique se presentant sous la forme de grains hydrosolubles, en particulier a base d'un extrait sec de ginkgo biloba, et son procede de preparation
FR2634376B1 (fr) * 1988-07-21 1992-04-17 Farmalyoc Nouvelle forme unitaire, solide et poreuse comprenant des microparticules et/ou des nanoparticules, ainsi que sa preparation

Also Published As

Publication number Publication date
DE69101792T2 (de) 1994-08-18
JP2912459B2 (ja) 1999-06-28
DK0438358T3 (da) 1994-06-06
EP0438358B1 (de) 1994-04-27
ES2063455T3 (es) 1995-01-01
ATE104847T1 (de) 1994-05-15
DE69101792D1 (de) 1994-06-01
FR2657258A1 (fr) 1991-07-26
EP0438358A1 (de) 1991-07-24
JPH04210912A (ja) 1992-08-03

Similar Documents

Publication Publication Date Title
GR3006518T3 (de)
DE3750431D1 (de) Stabilisiertes Arzneimittel und dessen Herstellung.
HU912266D0 (en) Process for the production of solid medical preparations with controlled portioning of the active agents for oral use
CS553490A3 (en) Transdermal therapeutic system
DE3579655D1 (de) Arzneimittel zur externen anwendung enthaltend aktives vitamin-d3.
NO874869D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive forbindelser.
GR3032673T3 (en) Use of an effective quantitiy of active substances for the treatment of mixed skin.
NO882406L (no) Fremgangsmaate for fremstilling av terapeutisk aktive urinstoff- og karbamat-forbindelser.
EG18379A (en) Novel pharmacological compounds
NO173653C (no) Analogifremgangsmaate for fresmstilling av terapeutisk aktive 6-benzoksazinyl-og 6-benzotianzinyl-2,3,4,5-tetrahydropyridazin-3-oner
NO883750D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive piperidinderivater.
NO910874D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive piperidinderivater.
NO873108D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive 1,4-benzodiazepiner.
DE3782531D1 (de) Optisch aktive verbindung und fluessigkristalline zusammensetzung.
FR2657258B1 (de)
NO881768D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive 1,3-dioksaner.
NO165542C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 5-aryl-2,4-dialkyl-3h-1,2,4-triazol-3-thioner.
ZA917601B (en) Combinations of active compounds of the pyrethroid type,containing benfluthrin and prallethrin
NO892871D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive forbindelser.
NO164973C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive gem-dihalo- og tetrahalo-1,2-diamino-4,9,-diaza-dodecaner.
EP0132772A3 (en) Fr-900216 substance obtainable by cultivating atcc 20577 for use as an active therapeutic substance and pharmaceutical antitumor composition comprising fr-900216 substance
EP0464210A4 (en) Novel platinum complex and antitumor drug containing the same as active ingredient
NO882282D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive pyrazin-amider.
GB2185478B (en) Novel e-valerolactam, pharmacologically active compositions thereof, processes for the preparation thereof and their medical use
GB2185479B (en) Novel amides, pharmacologically active compositions thereof, processes for the preparation thereof and their medical use

Legal Events

Date Code Title Description
ST Notification of lapse